Jens Modrof

995 total citations
23 papers, 736 citations indexed

About

Jens Modrof is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Animal Science and Zoology. According to data from OpenAlex, Jens Modrof has authored 23 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Animal Science and Zoology. Recurrent topics in Jens Modrof's work include Viral gastroenteritis research and epidemiology (10 papers), Viral Infections and Vectors (9 papers) and Viral Infections and Outbreaks Research (7 papers). Jens Modrof is often cited by papers focused on Viral gastroenteritis research and epidemiology (10 papers), Viral Infections and Vectors (9 papers) and Viral Infections and Outbreaks Research (7 papers). Jens Modrof collaborates with scholars based in Austria, Germany and United States. Jens Modrof's co-authors include Stephan Becker, Hans‐Dieter Klenk, Elke Mühlberger, Thomas R. Kreil, Maria R. Farcet, Bettina Hartlieb, Polly Roy, Johanna Kindermann, Mei‐ying W. Yu and Andreas Berting and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Virology and Journal of Allergy and Clinical Immunology.

In The Last Decade

Jens Modrof

21 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jens Modrof Austria 15 586 173 83 73 57 23 736
Lin Eastaugh United Kingdom 15 525 0.9× 206 1.2× 89 1.1× 89 1.2× 71 1.2× 27 731
Ayan K. Chakrabarti United States 20 739 1.3× 190 1.1× 150 1.8× 120 1.6× 165 2.9× 29 951
Fen Huang China 21 724 1.2× 207 1.2× 43 0.5× 108 1.5× 154 2.7× 54 1.3k
Rodrigo Melim Zerbinati Brazil 10 582 1.0× 179 1.0× 68 0.8× 35 0.5× 18 0.3× 19 775
Eva Mittler United States 16 750 1.3× 332 1.9× 102 1.2× 106 1.5× 99 1.7× 25 976
Stephanie Wurr Germany 10 683 1.2× 279 1.6× 109 1.3× 124 1.7× 154 2.7× 16 904
Verena Krähling Germany 17 663 1.1× 198 1.1× 41 0.5× 130 1.8× 113 2.0× 33 799
Paul Dremsek Germany 13 640 1.1× 59 0.3× 51 0.6× 94 1.3× 48 0.8× 15 957
Emily M. Deal United States 9 550 0.9× 226 1.3× 24 0.3× 74 1.0× 111 1.9× 10 679
Aykut Özdarendeli Türkiye 19 529 0.9× 99 0.6× 178 2.1× 100 1.4× 42 0.7× 50 844

Countries citing papers authored by Jens Modrof

Since Specialization
Citations

This map shows the geographic impact of Jens Modrof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Modrof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Modrof more than expected).

Fields of papers citing papers by Jens Modrof

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Modrof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Modrof. The network helps show where Jens Modrof may publish in the future.

Co-authorship network of co-authors of Jens Modrof

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Modrof. A scholar is included among the top collaborators of Jens Modrof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Modrof. Jens Modrof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farcet, Maria R., Jens Modrof, Gerhard Antoine, et al.. (2023). Detection of Minute virus of mice strains in different cell lines: Implications for adventitious agent testing. Biotechnology and Bioengineering. 121(1). 131–138.
2.
Kindermann, Johanna, et al.. (2020). Virus disinfection for biotechnology applications: Different effectiveness on surface versus in suspension. Biologicals. 64. 1–9. 20 indexed citations
3.
Modrof, Jens, et al.. (2020). SARS-CoV-2 and the safety margins of cell-based biological medicinal products. Biologicals. 68. 122–124. 14 indexed citations
4.
Farcet, Maria R., Jens Modrof, Andreas Schirmer, et al.. (2018). Continued use of poliovirus after eradication: hyper‐attenuated strains as a safe alternative for release testing of human immunoglobulins. Transfusion. 58(S3). 3084–3089. 5 indexed citations
5.
Modrof, Jens, et al.. (2017). Measles Virus Neutralizing Antibodies in Intravenous Immunoglobulins: Is an Increase by Revaccination of Plasma Donors Possible?. The Journal of Infectious Diseases. 216(8). 977–980. 8 indexed citations
6.
Kindermann, Johanna, et al.. (2015). Measuring the effectiveness of gaseous virus disinfectants. Biologicals. 43(6). 519–523. 4 indexed citations
7.
Farcet, Maria R., et al.. (2015). Hepatitis E virus and the safety of plasma products: investigations into the reduction capacity of manufacturing processes. Transfusion. 56(2). 383–391. 30 indexed citations
8.
Modrof, Jens, et al.. (2014). Reduction of spiked porcine circovirus during the manufacture of a Vero cell-derived vaccine. Vaccine. 32(18). 2056–2061. 11 indexed citations
9.
Modrof, Jens, Andreas Berting, & Thomas R. Kreil. (2014). Parallel Evaluation of Broad Virus Detection Methods. PDA Journal of Pharmaceutical Science and Technology. 68(6). 572–578. 1 indexed citations
10.
Farcet, Maria R., Johanna Kindermann, Jens Modrof, et al.. (2012). Chikungunya virus and the safety of plasma products. Transfusion. 52(10). 2122–2130. 22 indexed citations
11.
Farcet, Maria R., Johanna Kindermann, Jens Modrof, & Thomas R. Kreil. (2011). Inactivation of hepatitis A variants during heat treatment (pasteurization) of human serum albumin. Transfusion. 52(1). 181–187. 12 indexed citations
12.
Modrof, Jens, et al.. (2009). West Nile Virus Infection in Plasma of Blood and Plasma Donors, United States. Emerging infectious diseases. 15(10). 1668–1670. 28 indexed citations
13.
Modrof, Jens, et al.. (2009). Virus inactivation during the freeze‐drying processes as used for the manufacture of plasma‐derived medicinal products. Transfusion. 49(9). 1924–1930. 22 indexed citations
14.
Farcet, Maria R., et al.. (2009). Hepatitis A virus antibodies in immunoglobulin preparations. Journal of Allergy and Clinical Immunology. 125(1). 198–202. 24 indexed citations
15.
Berting, Andreas, et al.. (2008). Inactivation of parvovirus B19 during STIM‐4 vapor heat treatment of three coagulation factor concentrates. Transfusion. 48(6). 1220–1226. 6 indexed citations
16.
Modrof, Jens, Andreas Berting, Christina Forstner, et al.. (2007). Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins. Transfusion. 48(1). 178–186. 30 indexed citations
17.
Modrof, Jens, et al.. (2007). West Nile Virus Neutralization by US Plasma–Derived Immunoglobulin Products. The Journal of Infectious Diseases. 196(3). 435–440. 60 indexed citations
18.
Hartlieb, Bettina, Jens Modrof, Elke Mühlberger, Hans‐Dieter Klenk, & Stephan Becker. (2003). Oligomerization of Ebola Virus VP30 Is Essential for Viral Transcription and Can Be Inhibited by a Synthetic Peptide. Journal of Biological Chemistry. 278(43). 41830–41836. 63 indexed citations
19.
Modrof, Jens, et al.. (2002). Phosphorylation of VP30 Impairs Ebola Virus Transcription. Journal of Biological Chemistry. 277(36). 33099–33104. 107 indexed citations
20.
Modrof, Jens, Larissa Kolesnikova, Bettina Hartlieb, et al.. (2001). Phosphorylation of Marburg Virus VP30 at Serines 40 and 42 Is Critical for Its Interaction with NP Inclusions. Virology. 287(1). 171–182. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lin Eastaugh Breakdown of academic impact, for papers by Ayan K. Chakrabarti Breakdown of academic impact, for papers by Fen Huang Breakdown of academic impact, for papers by Rodrigo Melim Zerbinati Breakdown of academic impact, for papers by Eva Mittler Breakdown of academic impact, for papers by Stephanie Wurr Breakdown of academic impact, for papers by Verena Krähling Breakdown of academic impact, for papers by Paul Dremsek Breakdown of academic impact, for papers by Emily M. Deal Breakdown of academic impact, for papers by Aykut Özdarendeli
Rankless by CCL
2026